Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion description "[Lapatinib combined with capecitabine is an active treatment option for women with refractory HER2-positive MBC, including those with progressive CNS disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion evidence source_evidence_literature NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion SIO_000772 20179708 NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion wasDerivedFrom befree-20140225 NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_assertion wasGeneratedBy ECO_0000203 NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.
- befree-20140225 importedOn "2014-02-25" NP651409.RA8ynIEEXsZz10QxDHZkbjWTt1JmooYpHJAU3SpRZ3CGI130_provenance.